Novo Nordisk (NOVOB DC) and Hims & Hers (HIMS) are expected to announce a new partnership on Monday for Novo to sell its weight-loss drug on the Hims platform, Bloomberg reports citing sources
Context
The anticipated partnership between Novo Nordisk and Hims & Hers represents a strategic move for both companies, leveraging Hims' digital platform to enhance the distribution of Novo's weight-loss drug. This collaboration could signify a growing trend in the pharmaceutical sector towards digital health partnerships, potentially affecting competitors and opening new revenue streams for both parties involved.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#GLOBAL NEWS#GLOBAL EQUITIES